HIV therapy--what do we know, and when do we know it?

Editorial

Paul R Skolnik. N Engl J Med. 2003.

. 2003 Dec 11;349(24):2351-2.

doi: 10.1056/NEJMe038173.

No abstract available

Comment in

Comparison of regimens as initial therapy for HIV.
Clotet B. Clotet B. N Engl J Med. 2004 Mar 4;350(10):1053-4; author reply 1053-4. doi: 10.1056/NEJM200403043501018. N Engl J Med. 2004. PMID: 14999120 No abstract available.

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
Robbins GK, De Gruttola V, Shafer RW, Smeaton LM, Snyder SW, Pettinelli C, Dubé MP, Fischl MA, Pollard RB, Delapenha R, Gedeon L, van der Horst C, Murphy RL, Becker MI, D'Aquila RT, Vella S, Merigan TC, Hirsch MS; AIDS Clinical Trials Group 384 Team. Robbins GK, et al. N Engl J Med. 2003 Dec 11;349(24):2293-303. doi: 10.1056/NEJMoa030264. N Engl J Med. 2003. PMID: 14668455 Free PMC article. Clinical Trial.
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
Shafer RW, Smeaton LM, Robbins GK, De Gruttola V, Snyder SW, D'Aquila RT, Johnson VA, Morse GD, Nokta MA, Martinez AI, Gripshover BM, Kaul P, Haubrich R, Swingle M, McCarty SD, Vella S, Hirsch MS, Merigan TC; AIDS Clinical Trials Group 384 Team. Shafer RW, et al. N Engl J Med. 2003 Dec 11;349(24):2304-15. doi: 10.1056/NEJMoa030265. N Engl J Med. 2003. PMID: 14668456 Free PMC article. Clinical Trial.